Athersys Inc (NASDAQ:ATHX)
| 0.2301 Delayed Data As of Aug 16 |  -0.0108 / -4.31%Today’s Change | 0.17 Today|||52-Week Range 1.81 | -74.51% Year-to-Date |
Latest ATHX News | Press Releases
| Athersys (ATHX) Q2 2022 Earnings Call Transcript Aug 11 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 0.25 |
| Today’s open | 0.25 |
| Day’s range | 0.23 - 0.25 |
| Volume | 6,113,668 |
| Average volume (3 months) | 10,454,976 |
| Market cap | $68.1M |
Data as of 3:55pm ET, 08/16/2022
Growth & Valuation
| Earnings growth (last year) | +7.71% |
| Earnings growth (this year) | +35.90% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +282.92% |
| P/E ratio | NM |
| Price/Sales | 36.71 |
| Price/Book | 3.83 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AVCOAvalon Globocare Cor... | +0.01 | +1.67% |
| HARPHarpoon Therapeutics... | -0.03 | -1.40% |
| APLTApplied Therapeutics... | -0.07 | -5.11% |
| RUBYRubius Therapeutics ... | -0.02 | -2.95% |
Data as of 4:00pm ET, 08/16/2022
Financials
| Next reporting date | November 9, 2022 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $5.5M |
| Annual profit (last year) | -$87.0M |
| Net profit margin | -1,576.99% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cleveland, Ohio |
Forecasts
